SCHEMBL20064142

SCHEMBL20064142

FC(F)Oc1ccccc1OC1CCC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 8/20 0.47
PDE4A P27815 8/20 0.47
PDE4D Q08499 7/20 0.47
PDE4C Q08493 6/20 0.47
DRD1 P21728 1/20 0.44
HTR1A P08908 3/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
SLC6A2 P23975 2/20 0.42
SLC6A3 Q01959 2/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HRH1 P35367 2/20 0.39
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19527766 0.84 HTR1A (0.62) HTR1AADRA2AADRA2BADRA2CSLC6A2
SCHEMBL20063995 0.82 PDE4D (0.51) PDE4BPDE4APDE4DPDE4CKCNH2
SCHEMBL5344402 0.81 MCHR1 (0.49) PDE4BPDE4APDE4DPDE4CHTR1A
SCHEMBL19527662 0.79 PDE4D (0.43) PDE4BPDE4APDE4DPDE4CDRD1
SCHEMBL2242864 0.79 MCHR1 (0.51) PDE4BPDE4APDE4DPDE4CHTR1A
SCHEMBL19527552 0.79 HRH3 (0.48) HTR1AADRA2AADRA2BADRA2CKMT2A
SCHEMBL4654255 0.78 DRD1 (0.48) PDE4BPDE4APDE4DPDE4CDRD1
SCHEMBL19527742 0.78 DRD1 (0.38) PDE4BPDE4APDE4DPDE4CDRD1
SCHEMBL131273 0.78 PDE4A (0.50) PDE4BPDE4APDE4DPDE4C
SCHEMBL20064317 0.78 PDE4D (0.53) PDE4BPDE4APDE4DPDE4CKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069863-A1 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-19 WO disclosed